<SEC-DOCUMENT>0001213900-21-036167.txt : 20210708
<SEC-HEADER>0001213900-21-036167.hdr.sgml : 20210708
<ACCEPTANCE-DATETIME>20210708160824
ACCESSION NUMBER:		0001213900-21-036167
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210706
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210708
DATE AS OF CHANGE:		20210708

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aditxt, Inc.
		CENTRAL INDEX KEY:			0001726711
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823204328
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39336
		FILM NUMBER:		211080294

	BUSINESS ADDRESS:	
		STREET 1:		737 N. FIFTH STREET, SUITE 200
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23219
		BUSINESS PHONE:		909-488-0844

	MAIL ADDRESS:	
		STREET 1:		737 N. FIFTH STREET, SUITE 200
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aditx Therapeutics, Inc.
		DATE OF NAME CHANGE:	20201113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADiTx Therapeutics, Inc.
		DATE OF NAME CHANGE:	20171229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea143935-8k_aditxt.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;13 OR 15(d) of The
Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):&nbsp;<B>July
6, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aditxt, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-39336</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>82-3204328</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction<BR>
of incorporation)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer<BR>
Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>737 N. Fifth Street, Suite 200</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Richmond, VA</B></P></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23219</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code:&nbsp;<B>(909) 488-0844</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aditx Therapeutics, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2569 Wyandotte St., Suite 101</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mountain View, CA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&nbsp;8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I>&nbsp;General
Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title&nbsp;of&nbsp;each&nbsp;class</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading&nbsp;Symbol(s)</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name&nbsp;of&nbsp;each&nbsp;exchange&nbsp;on&nbsp;which&nbsp;registered</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, par value $0.001</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADTX</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Nasdaq Stock Market LLC</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company&nbsp;&#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5.03 Amendments to Articles of Incorporation of Bylaws; Change
in Fiscal Year.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Effective July 6, 2021, the
registrant (the &ldquo;Company&rdquo;) changed its corporate name from Aditx Therapeutics, Inc. to Aditxt, Inc. The name change was
effected following approval by the Company&rsquo;s Board of Directors through the filing of a Certificate of Amendment to the
Company&rsquo;s Amended and Restated Certificate of Incorporation. In accordance with Section 242(b)(1) of the Delaware General
Corporation Law, stockholder approval of the name change was not required. A copy of the Certificate of Amendment is attached hereto
as Exhibit 3.1 and incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The name change does not affect the rights of the
Company&rsquo;s security holders, creditors, customers or suppliers. The ticker symbol of the Company&rsquo;s common stock on The Nasdaq
Capital Market will remain &ldquo;ADTX.&rdquo; Following the name change, any stock certificates that reflect the Company&rsquo;s prior
name will continue to be valid. Certificates reflecting the new name will be issued in due course as old stock certificates are tendered
for exchange or transfer to our transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 8.01 Other Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 7, 2021, the Company
issued a press release announcing that it had relocated its corporate headquarters to Richmond, Virginia. A copy of the press release
is furnished as Exhibit 99.1 to this Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01 Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 9%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 90%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><A HREF="ea143935ex3-1_aditxt.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment, dated July 6, 2021</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><A HREF="ea143935ex99-1_aditxt.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated July 7, 2021</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADITX, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: July 8, 2021</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Corinne Pankovcin</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corinne Pankovcin</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea143935ex3-1_aditxt.htm
<DESCRIPTION>CERTIFICATE OF AMENDMENT, DATED JULY 6, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF AMENDMENT<BR>
<I>to the</I><BR>
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION<BR>
<I>of</I><BR>
ADITX THERAPEUTICS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ADITX THERAPEUTICS, INC.,
a corporation organized and existing under the General Corporation Law of the State of Delaware (the &ldquo;Corporation&rdquo;), does
hereby certify as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FIRST: The name of the Corporation
is Aditx Therapeutics, Inc. The Certificate of Incorporation was filed with the Secretary of State of the State of Delaware (the &ldquo;Secretary
of State&rdquo;) on September 28, 2017 and has been amended and restated by the Amended and Restated Certificate of Incorporation filed
with the Secretary of State on February 7, 2018, as amended on June 29, 2020 and May 24, 2021 (collectively, the &ldquo;Certificate of
Incorporation&rdquo;).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECOND: The Certificate of
Incorporation is hereby amended solely to reflect a change in the name of the Corporation by replacing ARTICLE&nbsp;I thereof with the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;The name of the corporation is
Aditxt, Inc. (the &ldquo;Corporation&rdquo;).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIRD: The board of directors
of the Corporation has adopted a resolution approving and declaring advisable the amendment described herein in accordance with the provisions
of Section&nbsp;242(b)(1)&nbsp;of the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOURTH: The amendment described
herein has been duly adopted in accordance with Section&nbsp;242 of the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FIFTH: This Certificate of
Amendment shall become effective on July 6, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Corporation
has caused this Certificate of Amendment to be duly adopted and executed in its corporate name and on its behalf by its duly authorized
officer on this 6th&nbsp;day of July, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>/s/ Amro Albanna</I></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: Amro Albanna</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ea143935ex99-1_aditxt.htm
<DESCRIPTION>PRESS RELEASE, DATED JULY 7, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aditxt Opens its First High-Capacity Immune
Monitoring Center in<BR>
 Richmond, VA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AditxtScore<SUP>TM </SUP>Center to Become Global
Headquarters for Aditxt as a Biotech<BR>
Innovator Focused on Immune Health</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Richmond, VA &ndash; DATE, 2021 &ndash; Aditxt, Inc. (Nasdaq: ADTX),
a biotech innovation company with a mission to improve the health of the immune system, today announced the opening of its AditxtScore&trade;
Center in&nbsp;Richmond, VA. This high-capacity, CLIA-validated immune monitoring center will be capable of processing several million
complex immune system reports per year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;The opening of the AditxtScore Center is a key step on AditxtScore&rsquo;s
path to market, serving as a critical enabler to commercializing a new platform for personalized health,&rdquo; said Amro Albanna, Co-founder
and Chief Executive Officer of Aditxt. &ldquo;In addition to its operational and commercial capabilities, this facility will also help
accelerate new AditxtScore application development activities to address markets with significant growth potential. We believe it will
now be possible to rethink the way providers diagnose and treat disease through a deeper, more nuanced understanding of the immune system.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Introduced earlier this year in a joint press conference with Governor
Ralph Northam,&nbsp;Richmond&nbsp;Mayor&nbsp;Levar Stoney&nbsp;and other local business executives and political officials, the AditxtScore
Center was built to support the growth of the AditxtScore platform, a pioneering new approach to immune and health monitoring that provides
a personalized profile of the immune system.&nbsp;By assessing an individual's immune biomarkers, AditxtScore is designed to measure indications
of immune response to specific disease. AditxtScore applications include the recently commercialized AditxtScore for COVID-19, developed
for use in detecting antibodies and neutralizing antibodies against SARS-CoV-2 antigens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AditxtScore is offered through authorized channel partners. To find
an AditxtScore Channel Partner near you, please visit www.aditxtscore.com. AditxtScore is available for use as a CLIA-validated laboratory
developed test (LDT). This test is not for self-diagnosis and is not cleared or approved by the FDA.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>About Aditxt</U>:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aditxt is developing technologies specifically focused on improving
the health of the immune system through immune monitoring and reprogramming. Aditxt&rsquo;s immune monitoring technology is designed to
provide a personalized comprehensive profile of the immune system. Aditxt&rsquo;s immune reprogramming technology is currently at the
pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted
organs, autoimmune diseases, and allergies. For more information, please visit: www.aditxt.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Certain statements in this press
release constitute &ldquo;forward-looking statements&rdquo; within the meaning of federal securities laws. Forward looking statements
include statements regarding the Company&rsquo;s intentions, beliefs, projections, outlook, analyses or current expectations concerning,
among other things, the Company&rsquo;s ongoing and planned product and business development; the Company&rsquo;s intellectual property
position; the Company&rsquo;s ability to develop commercial functions; expectations regarding product launch and revenue; the Company&rsquo;s
results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the
Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future
performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important
factors, as well as those risks more fully discussed in the section titled &ldquo;Risk Factors&rdquo; in the Company&rsquo;s most recent
Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company&rsquo;s
other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes
no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media and Investor Relations Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sunny Uberoi</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Communications Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aditxt</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@aditxt.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M +D# 2(  A$! Q$!_\0
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MY\J%QTZ_NP*SIF?2=)&IQE9&MM3F?8PP&#DJ1GMC/6G[.+T7];_Y"]I):O\
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
